Real-world experience with the all-oral, interferon-free regimen of ombitasvir/paritaprevir/ritonavir and dasabuvir for the treatment of chronic hepatitis C virus infection in the German Hepatitis C Registry

2017 ◽  
Vol 24 (10) ◽  
pp. 840-849 ◽  
Author(s):  
T. M. Welzel ◽  
H. Hinrichsen ◽  
C. Sarrazin ◽  
P. Buggisch ◽  
A. Baumgarten ◽  
...  
2020 ◽  
Vol 40 (4) ◽  
pp. 758-768 ◽  
Author(s):  
Chen‐Hua Liu ◽  
Chun‐Jen Liu ◽  
Chien‐Ching Hung ◽  
Szu‐Min Hsieh ◽  
Tung‐Hung Su ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document